Neutrophil‐To‐Lymphocyte Ratio and Survival in Pembrolizumab‐Treated Oropharyngeal Cancer
Year: 2026
Type: article
Study design: Observational Study
Source: Head & Neck
DOI: 10.1002/hed.70312
Institution: University of California, San Francisco
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7160776060
